You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.